Zoladex

€80.00

Zoladex (goserelin acetate) is a gonadotropin-releasing hormone (GnRH) agonist used in gender-affirming hormone therapy to suppress testosterone production. It is commonly prescribed for transgender women and non-binary individuals assigned male at birth (AMAB) who are seeking to reduce masculinizing effects and support feminization.

Zoladex provides long-term hormone suppression with infrequent dosing, helping maintain consistent hormonal levels, and supporting the feminization process when combined with estrogen therapy.

Composition:

  • Goserelin acetate, available in:

    • 3.6 mg implant (every 28 days)

    • 10.8 mg implant (every 12 weeks)